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Abstract
Background: Microglial activation plays a key role in the neuroinflammation associated with virtually all CNS
disorders, although their role in normal CNS physiology is becoming increasingly appreciated. Neuroinflammation is
often assessed by analyzing pro-inflammatory mediators in CNS tissue homogenates, under the assumption that
microglia are the main source of these molecules. However, other cell types in the CNS can also synthesize
inflammatory molecules. Hence, to enable direct analysis of microglial activities ex vivo, an efficient, reliable, and
reproducible method of microglial isolation is needed.
Methods: After enzymatic digestion of brain tissues and myelin removal, CD11b+ cells were isolated using
immunomagnetic separation, yielding highly purified microglia without astrocyte or neuronal contamination. We
used three methods of myelin removal (30% Percoll, 0.9 mol/l sucrose and anti-myelin magnetic beads), and
compared their effects on microglial viability and yield. To determine whether the isolation procedure itself
activates microglia, we used flow cytometry to examine microglial properties in brain-tissue homogenates and
isolated microglia from control and lipopolysaccharide (LPS) -treated mice.
Results: This method yielded a highly purified CD11b+ cell population with properties that reflected their in vivo
phenotype. The viability and yield of isolated cells were significantly affected by the myelin removal method.
Although the microglial phenotype was comparable in all methods used, the highest viability and number of
CD11b+ cells was obtained with Percoll. Microglia isolated from LPS-treated mice displayed a pro-inflammatory
phenotype as determined by upregulated levels of TNF-α, whereas microglia isolated from control mice did not.
Conclusions: Immunomagnetic separation is an efficient method to isolate microglia from the CNS, and is equally
suitable for isolating quiescent and activated microglia. This technique allows evaluation of microglial activities
ex vivo, which accurately reflects their activities in vivo. Microglia obtained by this method can be used for multiple
downstream applications including qRT-PCR, ELISA, Western blotting, and flow cytometry to analyze microglial
activities in any number of CNS pathologies or injuries.
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Introduction
Emerging evidence indicates the active involvement of
microglia, CNS resident innate immune cells, in virtually
all aspects of physiology in the healthy, diseased, and
injured CNS [1-3]. Microglia play a key role in the neu-
roinflammation associated with many neurodegenerative,
ischemic, and traumatic disorders [4-12]. The current
methods used to study microglial cells have a number of
limitations, thus there is a need for better tools enabling
analysis of microglial properties in various physiological or
pathological situations. Although immunohistochemistry
is invaluable in assessing many microglial properties such
as morphology, proliferation, site of activation and others,
this method is not generally suitable for analyzing cytokine
production, one of the key microglial responses to many
extrinsic and intrinsic CNS insults.
Neuroinflammation is often assessed by analyzing
cytokine expression in CNS tissue homogenates; how-
ever, this method lacks cell specificity even though
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microglia are usually presumed to be the source of
inflammatory molecule production in these samples.
Because astrocytes and even neurons can also exert
some immune activities, such as production of cytokines
[13-15], it is important to distinguish the cellular source
of these pro-inflammatory mediators. Hence, an effi-
cient, reliable and highly reproducible method of micro-
glial isolation is needed to allow direct analysis of their
properties ex vivo, regardless of their phenotype (e.g.
activated or quiescent).
Unlike astrocytes and neurons for which antibodies
recognizing extracellular epitopes of cell type-specific
membrane proteins are not available, the expression of
CD11b on microglia allows efficient antibody-based sep-
aration of these cells from CNS tissues. In this study, we
used immunomagnetic separation of CD11b+ cells, a
technique that reliably yields highly purified microglia
(without contamination by neuronal or glial cells) and
preserves their phenotype during isolation. The method
itself does not activate the isolated cells, and it is suitable
for both quantitative and qualitative analysis of RNA
and proteins in microglia. Although we have used this
method in earlier studies [16,17], and magnetic cell sep-
aration has been previously used to isolate microglia
from brain regions [18] and to separate them from
astrocytes in primary culture [19], here we report a
modified isolation method that does not require Percoll
density gradient centrifugation. We also provide a basic
characterization of the microglia isolated by this method,
their viability based on three different methods of myelin
removal, the effect of the isolation procedure itself on
the microglial phenotype, and the efficiency with which
microglia can be isolated. These parameters, which were
not evaluated in previous studies, are critical for asses-
sing the utility of this method for studying
microglial contributions to neuroinflammation.
Methods
Animals
All experiments were conducted in AAALAC-accredited
facilities under protocols approved by the University of
Wisconsin Institutional Animal Care and Use Committee.
Male adult (2–4 month old) ICR/CD1 mice (Charles
River, Wilmington, MA, USA) were housed under stand-
ard conditions (12 hours light/dark cycle, with water and
food available ad libitum).
LPS treatment - Lipopolysaccharide (LPS; E. coli 011:
B4, Sigma Chemical Co., Missouri, MO, USA) at a dose
of 1 mg/kg body weight or vehicle (PBS; 100 μl) were
administered to mice by intraperitoneal (i.p.) injection.
Microglial cells were isolated from brains 20 hours post-
injection.
Macrophage isolation - Macrophages were obtained by
peritoneal lavage with 10 ml of cold HBSS.
Microglial isolation
Microglial cells were isolated from brains as we described
previously [17]. The overview of the method is depicted in
Figure 1. Briefly, after perfusion with ice-cold PBS, brains
were dissected, weighed, and enzymatically digested using
Neural Tissue Dissociation Kit (Miltenyi Biotec, Germany)
for 35 min at 37°C (if necessary, the digestion can be
performed on ice, but this extends the digestion time).
Further processing was performed at 4°C. Tissue debris
was removed by passing the cell suspension through a
40 μm cell strainer. After myelin removal (see below), cells
were stained with PE-conjugated anti-CD11b antibodies
(Miltenyi Biotec, Germany) in IMAG buffer (PBS supple-
mented with 0.5% BSA and 2 mM EDTA) for 10 minutes
followed by incubation for 15 minutes with anti-PE mag-
netic beads. CD11b+ cells were separated in a magnetic
field using MS columns (Miltenyi Biotec, Germany). The
amounts of antibodies and magnetic beads were calculated
based on the number of cells obtained after myelin re-
moval, using the manufacturer’s guidelines. Both the
CD11b+ and CD11b- (effluent) fractions were collected
and used for further analyses.
Myelin removal methods
Percoll
After enzymatic dissociation, cells were resuspended in
30% Percoll (GE Healthcare, Princeton, NJ, USA) and
centrifuged for 10 minutes at 700 g. The supernatant
containing the myelin was removed, and the pelleted
cells were washed with HBSS, followed by immunomag-
netic isolation as described above.
Sucrose
Dissociated cells were resuspended in 0.9 mol/l sucrose
prepared in HBSS, and processed as described for the
Percoll method.
Anti-myelin beads
Cells were resuspended in IMAG buffer supplemented with
magnetic myelin removal beads (200 μl/brain; Miltenyi
Biotec) and incubated for 15 minutes. Myelin was removed
by magnetic separation using LS columns (Miltenyi Biotec),
with three columns used per brain. The cells were collected
and processed as described above.
Cell viability
Isolated CD11b+ cells were stained with Trypan blue and
the numbers of live and dead cells were counted under
the microscope based on dye exclusion. Alternatively,
cells were stained with Live/Dead fixable green Stain in
accordance with the manufacturer’s protocol (Invitrogen,
Carlsbad, CA, USA). This staining is compatible with
subsequent cell fixation/permeabilization procedures
and intracellular staining for flow cytometry analysis.
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Flow cytometry
CD11b+ cells and the effluent fractions (CD11b-negative
cells) obtained from the isolation procedure were resus-
pended in IMAG buffer and immunostained with anti-
CD45 antibodies (BD Pharmingen) for 10 minutes at 4°C.
After washing, the cells were permeabilized and fixed
(BD Cytofix/Cytoperm Solution; BD Biosciences) for
25 minutes at 4°C, followed by intracellular staining
with antibodies for GFAP (Cell Signaling, Danvers,
MA, USA) or NeuN (Millipore Billerica, MA, USA)
in Perm/Wash buffer (BD Biosciences). GFAP and
CD45 antibodies were fluorochrome-conjugated, and
used at final dilutions of 1:100. For NeuN staining,
secondary goat anti-mouse fluorochrome-conjugated
antibodies were used at a dilution 1:1000 (Invitrogen,
Carlsbad, CA, USA). Finally, the cells were fixed with
1.6% paraformaldehyde and stored at 4°C until ana-
lysis by flow cytometry (within 24 hours).
TNF-α immunostaining
Whole brain homogenates and isolated CD11b+ cells
were obtained from control (PBS) mice or mice injected
with LPS, as described above. Cells were resuspended in
DMEM supplemented with 10% FBS, penicillin/strepto-
mycin and 3 μl/ml of GolgiPlug (BD Biosciences), and
incubated at 37°C for 4 hours. The cells were then pro-
cessed for intracellular staining as described above with
APC-conjugated TNF-α antibodies (1:100 dilution; BD
Pharmingen).
RNA isolation and qRT- PCR
RNA isolation and quantitative reverse transcriptase
(qRT)-PCR was performed as we described in detail
previously [16,17]. Briefly, cells were resuspended in Tri-
Reagent (Sigma, MO, USA) and total RNA was isolated
in accordance with the manufacturer’s protocol. MMLV
reverse transcriptase (Invitrogen) was used to synthesize
cDNA from 0.5 μg of total RNA. Quantitative PCR was
performed using Power SYBR Green solution (Applied
Biosystems, Foster City, CA, USA) with gene expression
normalized to 18 S. Primer sequences are provided in
Table 1. Relative expression levels were determined by
the ΔΔCt method, and the data are expressed as the fold
change relative to the sample indicated in each figure.
Gene expression was considered undetectable if the Ct
value was greater than 35 cycles.
Statistical analysis
Each experiment was performed independently at least
three times. Results are expressed as the mean± SE. The
significance of the difference between means was
assessed by a Student’s t-test, and P< 0.05 was consid-
ered significant. Statistical analyses were performed
using SigmaStat software (Systat, San Jose, CA, USA).
Results
Viability and yield of CD11b+ cells
Because myelin can interfere with downstream applica-
tions such as immunomagnetic cell separation or flow
Myelin removal (4° C) 
35 min
CD11b staining (4° C)
25 min
Magnetic bead conjugation(4° C)
30 min
Column separation (4° C)
15 min
Total time 2h 45 min 
Enzymatic digestion (37° C or 4° C) 
40 min
Perfusion and tissue dissection (4° C) 
20 min
Figure 1 Flow chart of CD11b+ cell isolation. Animals were
perfused with ice-cold PBS to remove circulating immune cells.
Brains were dissected and tissue was gently dissociated using
enzymatic digestion. Myelin was removed using one of three
different methods (Percoll or sucrose centrifugation, or myelin
magnetic beads). Cells were stained with anti-CD11b antibodies and
then incubated with magnetic beads. Samples were extensively
washed on columns in a magnetic field to obtain the CD11b+ or
effluent (CD11b-) cell fractions. The total time for isolation was less
than 3 hours.
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cytometry, its removal is recommended for the adult ro-
dent CNS. We found that cell viability and yield
depended on the myelin removal method (Table 2). We
tested three different methods for myelin removal: cen-
trifugation in either 30% Percoll or 0.9 mol/l sucrose, or
myelin removal magnetic beads with subsequent column
separation in a magnetic field. We found that cell viabil-
ity was highest using Percoll, followed by anti-myelin
beads, as determined by either Trypan blue exclusion
(Table 2) or cell staining with the Live/Dead stain
(Figure 2). The number of recovered viable cells using
the Percoll method was almost twice that of the sucrose
method (Table 2). The proportion of viable cells assessed
by Live/Dead staining (Figure 2) appears to be higher
than with Trypan blue exclusion (Table 2). This is likely
due to the difficulty in distinguishing cell debris from
dead cells under the microscope; cell debris can be gated
out in flow cytometry analysis based on forward and side
scatter parameters.
Analysis of the CD11b+ fraction
The cells in the CD11b+ fraction were analyzed by flow
cytometry and qRT-PCR for the expression of key mar-
kers distinguishing microglia, astrocytes, and neuronal
cells. In the CD11b+ fraction, we found that less than 1%
of the cells were GFAP+, and NeuN+ cells were un-
detectable, indicating high purity of CD11b+ cells iso-
lated from brain tissue. We identified two CD11b+ cell
populations in brain that differed in their expression
levels of CD45 and CD11b, as assessed by flow
cytometry (Figure 3A). Microglia, identified as CD11b+
and CD45low, comprised the highest proportion of cells
(88–96%). We obtained similar results with all three
methods of myelin removal. Further analysis of CD45high
and CD45low cells revealed differences in their forward
and side scatter properties (Figure 3B), suggesting that
CD45high cells are larger than CD45low cells. In addition,
CD45high cells also expressed higher levels of CD11b
(Figure 3C). These data suggest that CD45low and
CD45high cells are distinct populations. However, it
remains to be determined whether these populations are
also functionally distinct, and how their relative propor-
tions change in different physiological and pathological
conditions.
To test whether this method is suitable for isolation of
cells with a wide range of CD11b expression levels, we
subjected cells obtained by peritoneal lavage containing
predominantly monocytes, macrophages, and dendritic
cells, to the same immunomagnetic isolation procedure
(Figure 4). The fluorescence intensity of CD11b protein
levels in the peritoneal lavage spanned almost three
orders of magnitude (Figure 4A). After immunomagnetic
separation, there was complete recovery of CD11b+ cells
suggesting that this method is suitable for isolating cells
with a wide range of CD11b expression (Figure 4B).
Analysis of mRNA from the CD11b+ fraction obtained
from brains showed high levels of CD11b expression
and undetectable levels of GFAP and NeuN, which are
markers of astrocytes and neurons, respectively
(Figure 5D).
Analysis of the CD11b- fraction
Flow cytometry analysis confirmed the absence of
CD11b+ cells in the effluent fraction, indicating high effi-
ciency of CD11b+ cell separation from the cell suspen-
sion (Figure 5A). As expected, many GFAP+ and NeuN+
cells were detected in this fraction (Figures 5B, C). The
analysis of mRNA by qRT-PCR confirmed high levels of
NeuN and GFAP mRNA in the effluent fraction, and un-
detectable levels of CD11b mRNA (Figure 5D).
Microglial phenotype
To determine whether the isolation procedure itself alters
microglial properties, and if microglia retain their in vivo
phenotype during the isolation procedure, we compared
the production of TNF-α in microglia isolated from con-
trol or LPS-treated mice. LPS is a well-established inducer
of neuroinflammation and microglial activation. We found
a 7-fold increase in microglial mRNA levels of this
cytokine after LPS administration, consistent with a pro-
inflammatory phenotype (Figure 6A).
This observation was also confirmed by flow cytome-
try analysis of TNF-α protein levels. We examined the
production of TNF-α in microglial cells before and after
Table 1 Primer sequences
Direction Sequence 5′!3′










Table 2 Comparison of the number of isolated live CD11b
+ cells determined by Trypan blue exclusion (n =3)
Live cells (%) Live cells/mg tissue Live cells/brain
Percoll 93 ± 0.9 2011 ± 167 994,000± 82,454
Anti-myelin
beads
81 ± 1.8 1792 ± 241 878,400± 110,963
Sucrose 61 ± 4.4 884± 88 409,791± 53,427
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their immunomagnetic isolation (by comparing TNF-α
levels in CD11b+ cells from brain-tissue homogenates
versus levels in isolated microglia), to assess the effects
of the isolation procedure itself on this indicator of
microglial activation. Although microglia in the normal,
healthy CNS contained low levels of TNF-α, we found
that there was a significant source of this protein in the
normal CNS that did not originate from microglia
(Figure 6B), as these cells were positive for TNF-α but
negative for CD11b.
Microglia subjected to the isolation procedure from
LPS-treated mice retained their pro-inflammatory
phenotype, whereas microglia isolated from control mice
maintained a quiescent phenotype as assessed by
CD11b, CD45, and TNF-α protein levels. The increase
in the frequency of TNF-α+/CD11b+ cells that was
induced by LPS was similar (6-fold) before (Figure 6C)
and after (Figure 6D) immunomagnetic separation, sug-
gesting that the isolation procedure does not further ac-
tivate them. Our results also showed that TNF-α was
upregulated predominantly in CD11b+/CD45low cells,
suggesting that microglia were the primary responders
to LPS challenge (Figure 6E). Interestingly, the relative
proportions of CD11b+ cells that are either CD45low or
CD45high also did not change after peripheral LPS ad-
ministration, suggesting that there is no detectable infil-
tration of peripheral CD11b+ cells into the CNS at this
time after intraperitoneal LPS injection. Importantly,
similar observations were made regardless of the method
used for myelin removal.
Discussion
We describe here an efficient method that is suitable for
the isolation of both quiescent and activated microglia
from the CNS, allowing for the evaluation of microglial
activities ex vivo, which accurately reflect their activities
in vivo. This method is especially valuable for studying
microglial properties in various CNS disorders; a better
understanding of their role in pathological processes and
the mechanisms that regulate their activities will enable
the development of new strategies to therapeutically tar-
get microglia.
We identified two populations of CD11b+ cells in the
healthy brain, which differ in their CD45 expression
levels. Microglia that express very low CD45 levels com-
prised the largest population of CD11b+ cells in the CNS
(about 88-96%). Macrophages and/or other myeloid cells
were also present, but in much less abundance. However,
it is likely that the proportions of these subpopulations
will differ under various pathological conditions, and
therefore it will be important to establish the abundance
of each population during the CNS condition of interest
before making judgments about microglial activities.
We used three different methods for myelin removal
from the adult CNS, a step necessary for downstream
applications such as immunostaining or flow cytometry.
We found that all methods were very efficient at remov-
ing myelin, and none of them changed microglial prop-
erties. Several factors may be considered when deciding
which method to choose for myelin removal. The most
practical one is cost, with sucrose being the most cost-
effective method of the three evaluated here. However,
downstream applications should also be taken into ac-
count, especially when interested in quantifying changes
in microglial cell numbers or in obtaining larger num-
bers of cells. In this case, Percoll is a cost-effective solu-
tion and likely the best option as cell yield and viability
is much improved compared to sucrose.
Many pro-inflammatory cytokines, including TNF-α,
are secreted from macrophages upon LPS stimulation by
constitutive exocytosis. This process is dependent on
receptor-mediated transcription; for example, through
Toll-like receptor 4 after LPS administration [20,21]. In







Figure 2 Yield and survival of isolated CD11b+ cells. Brain tissues were enzymatically digested followed by centrifugation in (A) 30% Percoll
or (B) 0.9 mol/l sucrose to remove myelin. After immunomagnetic separation of the CD11b+ cell population, cells were stained with Live/Dead
fixable green stain, and the proportion of surviving cells was determined by flow cytometry.
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quickly trafficked in recycling endosomes via the Golgi
complex to the membrane surface, where it is cleaved by
TNF-α-converting enzyme, followed by the rapid release
of the ectodomain as a soluble cytokine [21], a process
that can take less than 20 minutes. Therefore, when ana-
lyzing protein levels of these cytokines, it is often neces-
sary to use an inhibitor of the Golgi apparatus in order
to accumulate proteins intracellularly and enable their
detection. Indeed, when analyzing isolated microglial
cells from LPS-treated animals without prior incubation
in the presence of GolgiPlug, we were unable to detect
TNF-α by flow cytometry in CD11b+ cells despite detec-
tion of strongly upregulated levels of TNF-α mRNA.
Using the same method of microglial analysis ex vivo, we
have previously reported strong upregulation of many
inflammatory genes including TNF-α, IL-1β, IL-6 and
IL-10 after LPS injection directly into the brain [17], as
well as changes in purinergic receptor expression with
age and sex [16]. Because of limitations with all cur-
rently available methods used in microglial research, we
can only approximate the true microglial phenotype




Figure 3 Analysis of the CD11b+ fraction. (A) After isolation, cells in the CD11b+ fraction were stained with anti-CD45 antibodies and analyzed
by flow cytometry. Two CD45-expressing populations were identified: low (red) and high (blue). (B) Forward scatter (FSC) and side scatter (SSC)
characteristics of CD11b+/CD45low (red) and CD11b+/CD45 high (blue) are shown. A histogram of FSC parameters comparing CD45low and
CD45high cells is shown on the right. (C) Histogram showing the differences in CD11b expression between CD45low and CD45high cell
populations.
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microglial properties under different conditions or treat-
ments suggests that the method for microglial isolation
described here is suitable to assess changes in microglial
activities in many CNS pathologies.
In the present study, we found that there are significant
levels of TNF-α that do not originate from microglia in
the healthy CNS. Although it was beyond the scope of the
present study to identify the cellular source or the bio-
logical effects of this non-microglial TNF-α, this is an
important consideration when evaluating neuroinflamma-
tion based on the expression of pro-inflammatory cyto-
kines in CNS homogenates composed of multiple cell
types. Because microglial cells are among the least abun-
dant populations in the CNS, subtle changes in microglial
gene expression may not be detectable. Moreover, other
cell types in the CNS may express pro-inflammatory cyto-
kines or growth factors, as we show here; therefore, it is







Figure 4 Analysis of peritoneal macrophages. (A) Peritoneal lavage samples containing abundant macrophages were subjected to
immunomagnetic separation for CD11b+ cells (B). Cell populations expressing a range of CD11b levels were isolated with comparable efficiency.



















































CD11b+ fraction Effluent fraction
D
Figure 5 Analysis of the CD11b- (effluent) fraction. Cells in the effluent fraction were stained with anti-GFAP or anti-NeuN antibodies. (A) No
CD11b+ cells were detected in this fraction, suggesting high efficiency of the CD11b+ cell separation from CNS tissues. As expected, this fraction
consisted of large populations of (B) astrocytes and (C) neurons. (D) These observations were confirmed by mRNA analysis. High expression of
CD11b was found only in the CD11b+ fraction, with undetectable levels in the effluent fraction, whereas high mRNA levels of GFAP and NeuN
were found only in the effluent fraction.








































Figure 6 (See legend on next page.)
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molecules found in whole-tissue homogenates always
reflects microglial activities.
Another advantage provided by this method is the
ability to investigate immune responses, such as cytokine
production, in CNS cell populations that are depleted of
microglia and/or macrophages, an approach that is not
possible when microglia are isolated using a Percoll gra-
dient. Simultaneous examination of both the CD11b−
and CD11b+ fractions will provide important insights
into neuroinflammatory responses in various patho-
logical conditions, and distinguish responses originating
in microglia from those of other CNS cell types.
Conclusion
This method provides a highly efficient and powerful
tool for investigating microglial properties ex vivo.
Microglia can be isolated either from the whole CNS or
from distinct CNS regions as small as the hippocampus.
Based on the cell surface marker and inflammatory gene
expression parameters we have assessed here, the
method itself does not appear to activate the microglia,
and the isolated cells retain properties very similar to
those in vivo, making this method suitable for the assess-
ment of multiple microglial parameters. The use of this
technique will enable the specific evaluation of microglia
in the context of neuroinflammation, instead of inferring
their activities based on inflammatory gene expression
from mixed-cell CNS homogenates.
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